Plasma Glucose Estimation From Whole Blood Sensor Response

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for measuring glucose concentration in blood plasma using whole blood samples face discrepancies due to hematocrit values, especially at high glucose concentrations, leading to inaccuracies.

Innovation Solution

A method and apparatus that utilize electrochemical sensors to measure whole blood glucose concentration, calculate a correction value based on hematocrit and sensor response, and apply formulas to correct for discrepancies, enabling accurate plasma glucose concentration determination.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If glucose concentration is measured using whole blood sample with conventional correction formula, then measurement process is simplified, but measurement precision deteriorates due to hematocrit value discrepancies

Engineering Contradiction:
Improvemeasurement process simplicityVSAvoidglucose concentration accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent introduces a response index as a new parameter to characterize sensor performance variations. By incorporating this parameter into the correction formula along with hematocrit value, the system dynamically adjusts the correction based on actual sensor response, thereby maintaining measurement precision across different hematocrit conditions while preserving the simplicity of whole blood measurement.

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If conventional correction formula is used, then device complexity is reduced, but measurement precision deteriorates at high glucose concentrations

Engineering Contradiction:
Improvecorrection system simplicityVSAvoidhigh glucose concentration accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent modifies the correction approach by introducing the response index parameter that captures sensor behavior at different glucose concentrations. The corrected formula incorporates this parameter to compensate for non-linear sensor responses at high glucose levels, thereby extending the accurate measurement range without significantly increasing device complexity.

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If simple correction based on hematocrit is applied, then ease of operation is maintained, but reliability deteriorates due to sensor response variations

Engineering Contradiction:
Improvecorrection application simplicityVSAvoidmeasurement consistency
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent introduces the response index as an additional correction parameter that accounts for sensor-to-sensor variations and environmental effects. By incorporating this parameter into the correction formula, the system achieves more reliable and consistent measurements across different sensors and conditions while maintaining operational simplicity through automated calculation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables accurate measurement of plasma glucose concentration from whole blood samples, independent of hematocrit values, by correcting for sensor response and hematocrit effects using specific formulas.

Implementation Method 1

measuring a whole blood component concentration using a whole blood sample, using an electrochemical sensor method

Methodology Applied
Scientific EffectElectrochemical sensor method:

Data Source

PatentEP4679074A1Component concentration measurement method
Publication Date: 2026.01.14 ARKRAY INC
  • EP4679074A1 patent drawingFigure 1~2
  • EP4679074A1 patent drawingFigure 3~4
  • EP4679074A1 patent drawingFigure 5

AI summary

Provided is a method for reducing the discrepancy between a measured value of component concentration in whole blood and a measured value of component concentration in plasma. An aspect of the invention relates to a method for measuring a plasma component concentration using a whole blood sample. The method includes: measuring a whole blood component concentration using a whole blood sample, using an electrochemical sensor method; computing a correction value using a whole blood component concentration measured value obtained through the measurement, a hematocrit value of the whole blood sample, and a response index of a sensor used for the measurement of the whole blood component concentration; and computing a plasma component concentration using the correction value and the whole blood component concentration measured value.